Press Release
Category Added in a WPeMatico Campaign
-
CONCEPT MEDICAL ANNOUNCES PRELIMINARY 3-YEAR SIRONA DATA AT CHARING CROSS SYMPOSIUM 2026
LONDON, April 27, 2026 /PRNewswire/ — Concept Medical Inc., today announced the presentation of preliminary 3-year follow-up data from the…
Read More » -
PATEO Joins Forces with AUMOVIO: AI-Driven Intelligent Driving Globalization to Jointly Expand the Global High-Computing SDV Market
BEIJING, April 27, 2026 /PRNewswire/ — On April 25, at the Beijing International Automotive Exhibition, PATEO CONNECT Technology (Shanghai) Corporation (Stock…
Read More » -
Vertiv Strengthens Liquid-Cooling System Capability with Acquisition of Strategic Thermal Labs
Acquisition enhances engineering expertise for cold-plate design, server‑side liquid cooling and high-density thermal validation to improve system‑level performance, reliability, and…
Read More » -
VIAVI Announces Investment in PCIe 7.0 Protocol Analysis Testing Platform
New design will be showcased at PCI-SIG Devcon from May 6-7 CHANDLER, Ariz., April 27, 2026 /PRNewswire/ — VIAVI Solutions…
Read More » -
Hyperscale Data Subsidiary Ault Global Commodities Partners with Scottsdale Mint to Advance Company’s Precious Metals and Rare Earth Minerals Strategy
LAS VEGAS, April 27, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence (“AI“) data center company anchored…
Read More » -
ITURAN LOCATION AND CONTROL LTD. SCHEDULES FIRST QUARTER 2026 RESULTS RELEASE AND CONFERENCE CALL FOR MAY 26, 2026
Conference Call Scheduled at 9am Eastern Time AZOUR, Israel, April 27, 2026 /PRNewswire/ — Ituran Location and Control Ltd. (NASDAQ: ITRN),…
Read More » -
PATEO and NVIDIA Partner to Debut Pioneering Software-Hardware Integrated AI Box Solution
SHANGHAI, April 27, 2026 /PRNewswire/ — On April 23, PATEO reached a series of deep collaborations with NVIDIA and a leading…
Read More » -
Cellenkos, Inc. Announces FDA Clearance to Initiate Phase 2 Clinical Trial of CK0801 (Allogeneic Cord Blood-Derived Tregs) for Aplastic Anemia
Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs in transfusion-dependent aplastic anemia.…
Read More » -
illumend CEO Kristen Nunery Says The Real Measure of AI in COI Tracking Is Compliance Intelligence, Not Document Processing Speed
As AI becomes common across COI tracking platforms, Nunery urges non-insurance professionals to evaluate whether the technology delivers stronger compliance…
Read More »